Safety of intravitreal pegcetacoplan inpatients with neovascular age-related macular degeneration receiving anti-VEGF therapy

被引：0
|
作者：
Hu, Allen [1 ]
Esmaili, Daniel [2 ]
Ribiero, Ramiro [3 ]
Bliss, Caleb [3 ]
Jones, Daniel [3 ]
Brown, David [4 ]
机构：
[1] Meritus Med Ctr, Hagerstown, MD USA
[2] Retina Vitreous Associates Med Grp, Los Angeles, CA USA
[3] Apellis Pharmaceut Inc, Waltham, MA USA
[4] Retina Consultants Texas, Houston, TX USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2021年 / 62卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
427
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Switching intravitreal anti-VEGF treatment in neovascular age-related macular degeneration
    Kucukerdonmez, Cem
    Gelisken, Faik
    Yoeruek, Efdal
    Bartz-Schmidt, Karl Ulrich
    Leitritz, Martin Alexander
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2015, 25 (01) : 51 - 56
  • [2] Intravitreal anti-VEGF therapy in neovascular age-related macular degeneration: Bevacizumab versus Ranibizumab
    Zehetner, C.
    Kralinger, M. T.
    Kieselbach, G. F.
    SPEKTRUM DER AUGENHEILKUNDE, 2008, 22 (06) : 370 - 375
  • [3] Glaucoma progression in patients receiving intravitreal anti-VEGF treatment for neovascular age-related macular degeneration
    Pirinen, Inka
    Leinonen, Sanna
    Helminen, Mika
    Hujanen, Pekko
    Vaajanen, Anu
    Tuulonen, Anja
    Uusitalo-Jaervinen, Hannele
    ACTA OPHTHALMOLOGICA, 2023, 101 (03) : 261 - 265
  • [4] Neovascular age-related macular degeneration and anti-VEGF nonresponders
    Sheybani, Arsham
    Almony, Arghavan
    Blinder, Kevin J.
    Shah, Gaurav K.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2010, 5 (01) : 35 - 41
  • [5] Safety and efficacy of intravitreal anti-VEGF injections for age-related macular degeneration
    Jeganathan, V. Swetha E.
    Verma, Nitin
    CURRENT OPINION IN OPHTHALMOLOGY, 2009, 20 (03) : 223 - 225
  • [6] Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: Therapeutic Strategies
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2012, 229 (05) : 541 - 547
  • [7] VEGF levels in serum and the outcome of intravitreal anti-VEGF treatment in neovascular age-related macular degeneration
    Abedi, Farshad
    Wickremasinghe, Sanjeewa
    Islam, Amirul
    Guymer, Robyn H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [8] Third nerve palsy following intravitreal anti-VEGF therapy for bilateral neovascular age-related macular degeneration
    Micieli, Jonathan A.
    Santiago, Patrick
    Brent, Michael H.
    ACTA OPHTHALMOLOGICA, 2011, 89 (01) : E99 - E100
  • [9] Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy
    Bandello, Francesco
    Corvi, Federico
    La Spina, Carlo
    Benatti, Lucia
    Querques, Lea
    Capuano, Vittorio
    Naysan, Jonathan
    Chen, Xuejing
    Sarraf, David
    Parodi, Maurizio Battaglia
    Souied, Eric
    Freund, K. Bailey
    Querques, Giuseppe
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2016, 100 (12) : 1611 - 1616
  • [10] Anatomical outcomes of patients receiving 50 or more intravitreal anti-VEGF injections for neovascular age-related macular degeneration
    Arpa, Cristina
    Moraes, Gabriella
    Fasler, Katrin
    Fu, Dun Jack
    Wagner, Siegfried Karl
    Balaskas, Konstantinos
    Keane, Pearse Andrew
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
12345